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Abstract
Anxiety disorders are the most common of all psychiatric illnesses and result 
in significant functional impairment and distress. In DSM 5, anxiety disorders are 
divided into eleven subgroups. Anxiety, which we consider normal (mild and moder-
ate anxiety), plays an important role in the development of the individual. However, 
if the level of anxiety increases, it may lead to mental problems. A high level of 
anxiety, long duration, and intensification of anxiety symptoms may cause anxiety 
disorders. These are; separation anxiety disorder, selective mutism, panic disorder, 
agoraphobia, specific phobia, social anxiety disorder, generalized anxiety disorder, 
other unspecified anxiety disorder, anxiety disorder related to another medical con-
dition, anxiety disorder caused by substance or medication, anxiety disorders caused 
by substances and medication are unspecified anxiety disorders. Treatment methods 
used in anxiety disorders are individual psychotherapy, cognitive therapy, behavioral 
therapy, systematic sensitization, exposure, and psychopharmacology.
Keywords: anxiety disorders, panic disorder, phobia, social anxiety disorder, 
generalized anxiety disorder, selective mutism
1. Anxiety disorders
1.1 Anxiety concept
Anxiety is a feeling that individuals experience at different levels throughout 
their lives. Anxiety is a healthy, normal response to perceived threats or unique 
experiences, and it is a necessary motivating force for survival. Mild anxiety is 
a driving force necessary for adaptation and advancement to the higher stage of 
spiritual development. However, when the anxiety level increases too much, it, on 
the contrary, serves as a hindering function [1].
1.2 Anxiety and fear
Anxiety and fear are emotions that people are usually confused about. Fear is a 
response to a known threat. However, anxiety can be defined as fear, tension, uneasi-
ness, or restlessness expected from an unidentified or unknown source. We can 
evaluate anxiety as a cognitive state of fear [2]. Physical symptoms of anxiety include 
palpitations, difficulty breathing, rapid breathing, tremors in the hands and feet, 
and excessive sweating. Psychological symptoms, on the other hand, include dis-
tress, excitement, sudden feeling, and fear that something terrible will happen [3].
Anxiety, which we consider normal (mild and moderate anxiety), plays an 
important role in the development of the individual. However, if the level of anxiety 
increases, it may lead to mental problems. A high level of anxiety, long duration, 
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and intensification of anxiety symptoms may cause anxiety disorders. Anxiety can 
be evaluated as pathological when it begins to have an impact on social and occupa-
tional actions, achievement of desired goals, and emotional state [4].
In short, anxiety can be deemed pathological if the following situations occur:
a. When anxiety is not proportional to the situation that creates anxiety,
b. When anxiety inhibits social, occupational, and other important  functional 
areas.
Example: Ms. M., who was involved in a serious traffic accident a month ago, 
refuses to drive even to places in short distances. Her father has to take Ms. M. 
whenever she needs to go somewhere. Ms. M., who constantly refuses to drive, has 
even had to quit her job because of her anxiety about driving.
1.3 Epidemiology
Anxiety disorders are the most common of all psychiatric illnesses and result 
in significant functional impairment and distress [5, 6]. Its prevalence per year 
is reported as 17.7%. This rate is 30.5% for women and 19.2% for men, and the 
frequency decreases with the increase in socioeconomic level [7]. In a study con-
ducted by Özcan et al. (2006), anxiety disorder was found to be the most common 
diagnosis among 950 psychiatric patients, and it was mostly observed in women, 
housewives, married people, and people with a low education level [8].
2. Etiology of anxiety disorders
2.1 Biological factors
In twin studies conducted, it was concluded that genetics was a huge factor. 
Structural neuroimaging studies in patients with panic disorder indicate pathologi-
cal involvement in the temporal lobes, especially in hippocampus [9].
Although many neurotransmitters are effective in the pathophysiology of anxi-
ety disorders, disorders in serotonin, norepinephrine, and gamma-aminobutyric 
acid (GABA) appear to be the most important. GABA has an important place among 
the causes of anxiety disorder. As the drugs used in the treatment of anxiety disor-
ders increase GABA, it is thought that the insufficiency and imbalance in GABA are 
directly related to the anxiety experienced [3, 5]. Serotonin is another neurotrans-
mitter linked to anxiety disorder. Deficiency or an imbalance of serotonin in the 
amygdala is observed in anxiety-related disorders. It is known that there is imbal-
ance in the regions related to norepinephrine in anxiety disorders.
It has been revealed that the CRF (Corticotropin-Releasing Factor) system plays 
an important role among the biological causes of anxiety disorders [1].
2.2 Brain areas affected in anxiety disorders
The brain areas affected by anxiety disorders and the symptoms they cause are 
listed below:
• Amygdala: Fear, which is especially important in panic and phobic disorders.
• Hippocampus: Depends on memory which is related to fear responses.
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• Locus coeruleus: Vigilance
• Brain stem: respiratory movement, heartbeat
• Hypothalamus: activation of the stress response
• Frontal cortex: Cognitive interpretations
• Thalamus: Integration of sensory impulses
• Basal ganglia: Tremors [10]
3. Psychological theories
Psychodynamic Theory: According to the psychodynamic view, anxiety is 
a state of tension that emerges in the self as a result of threats originating from 
within and outside the individual. Starting from childhood, repressed emotions, 
desires, impulses, experiences occasionally disturb the individual’s self in the 
following years. A conflict arises between the self (ego), lower self (id), and upper 
self (superego), which creates anxiety in the individual. Anxiety is a harbinger of 
danger to the self, and the self tries to reduce anxiety by using self-defense mecha-
nisms [11].
Freud argued that the child experiences anxiety specific to each period during 
the development process. These are superego anxiety, castration anxiety, fear of 
losing love, separation anxiety, annihilation anxiety, and disintegration anxiety.
Behavioral Theory: According to this theory, anxiety is an emotional experi-
ence developed based on the urge to escape from congenital pain or suffering. 
This theory suggests that if an individual experiences intense fears and stressful 
events in early periods of life, s/he is likely to experience high levels of anxiety 
in his/her later life. Fear responses acquired through conditioning, observation, 
and social learning cause “escape” and “avoidance” behaviors to be triggered, 
thereby reducing anxiety. The escape and avoidance behaviors are thus rein-
forced, and when any kind of anxiety is experienced, they come into play and 
the anxiety is prevented from fading. Thus, the continuity of anxiety is ensured 
in this way [11].
Cognitive Theory: In Beck’s theory, how we interpret and perceive events deter-
mines our emotions; in other words, it is the meaning attributed to them rather 
than the events themselves that trigger our emotions. This interpretation depends 
on the characteristics of the environment in which the event occurs, the mood at the 
time of the event, and the past experiences of the individual. Individuals experience 
anxiety due to their false reasoning and irrational beliefs [1, 3].
4. Classification of anxiety disorders
In DSM 5, anxiety disorders are divided into eleven subgroups. These are:
• Separation anxiety disorder,
• Selective mutism,
• Panic disorder,
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• Agoraphobia,
• Specific Phobia,
• Social anxiety disorder,
• Generalized anxiety disorder,
• Other unspecified anxiety disorder,
• Anxiety disorder related to another medical condition,
• Anxiety disorder caused by substance or medication,
• Anxiety disorders caused by substances and medication are unspecified 
anxiety disorders [12].
4.1 Separation anxiety disorder
Separation anxiety disorder can be defined as experiencing fear and anxiety that 
is more than expected and repetitive in terms of developmental level resulting from 
separation from home or someone the person is attached to for at least four weeks 
in children, and for at least six months or longer in adults. It is seen that individuals 
with separation anxiety disorder do not want to go to school or elsewhere because of 
the fear of separation. The main feature of separation anxiety disorder is excessive 
anxiety caused by leaving the mother, father, home or familiar environment. It is 
seen equally in boys and girls.
Etiology: According to the psychodynamic approach, children who are attached 
ambivalently are very busy with the care of their caregivers, which reduces their 
exploration behaviors of their environment and thus causes separation anxiety to 
develop. Stressful events such as parental divorce, illness, loss are important risk 
factors for separation anxiety disorder. In a study, it was found that the depressive, 
cyclothymic, irritable and anxious temperament scores of the mothers of children 
with separation anxiety disorder were higher than the control group [13].
Symptoms in separation anxiety disorder differ according to the developmental 
period. In children aged 5-8 years, the fear of a bad event and rejection of school, 
intense distress during separation at the age of 9-12, school refusal in adolescents 
aged 13-16, and physical complaints appear as symptoms.
Comorbidity: Frequently, depression, bipolar disorder, hyperactivity disorder, 
personality disorders and other anxiety disorders are seen together.
Treatment: In the treatment of separation anxiety disorder, the most important 
point is planning to include the family, school and child. Cognitive therapy is one 
of the effective methods. Antidepressants, selective serotonin reuptake inhibitors, 
are used in drug therapy. One study suggested that vilazodone can be used in the 
treatment of separation anxiety disorder [14].
4.2 Selective Mutism
The most important feature of this disorder is that although the individual can 
speak in other situations, s/he constantly does not speak in certain specific social 
situations (when s/he meets people s/he does not know, etc.) where s/he is expected 
to speak. The disorder must last at least one month and affect the person’s educa-
tion, work success, and social life. It usually occurs in the preschool period.
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Etiology: In the etiology of the disorder, there are reasons such as delay in lan-
guage development, communication defects, lack of communication, presence of 
psychiatric disorders in the family, and overprotection of the family.
Comorbidity: Social phobia, obsessive-compulsive disorder, speech and language 
disorders are among the disorders accompanying selective speech disorders.
Treatment: Behavioral treatments, pharmacological treatments, group and 
family therapies are effective in treatment. It has been stated that the cognitive-
behavioral approach especially encourages verbal and non-verbal forms of com-
munication. In family therapy, it is important to identify healthy and dysfunctional 
family relationships and to raise awareness of family members about unhealthy 
communication patterns and behaviors. Selective serotonin reuptake inhibitors are 
preferred in pharmacological treatment.
4.3 Panic disorder
In the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition 
(DSM-5) [American Psychiatric Association (APA)] it is stated that at least four 
of the following symptoms must be present to determine the presence of a panic 
attack. These are:
• Palpitations, pounding heart or accelerated heart rate
• Sweating
• Shaking or trembling
• Feeling short of breath or smothering
• Choking sensation
• Chest pain or discomfort
• Nausea or abdominal distress
• Feeling dizzy, lightheaded, unsteady or faint
• Chills or hot flushes
• Paresthesias (tingling and numbness sensations)
• Derealization (unreal feelings) or depersonalization (feelings of being 
detached from oneself)
• Fear of losing control and going crazy
• Fear of dying [12]
Panic disorder, which is a very old disease, is a syndrome characterized by 
sudden and extreme anxiety with unreasonable and unpredictable panic attacks. 
Its most important feature is that it is accompanied by intense physical discomfort. 
Panic attacks can occur only once, or frequently, on a weekly, monthly or even 
annual basis. Panic attack disorder is usually seen in the 20s. The panic attack is 
an unreasonable and severe state of anxiety. During panic attacks, symptoms such 
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as palpitations, accelerated heart rate, sweating, trembling/shaking, shortness 
of breath, feeling of choking, breathlessness, chest pain, fainting, fear of losing 
control or going crazy, numbness, tingling, chills or hot flushes can be seen.
The presence of a medical drum that may cause anxiety should first be investi-
gated in a patient presenting with panic attack. All the drugs used by the individual 
should be questioned, and the side effects of the drugs should be considered. Below 
are some medical conditions that cause symptoms similar to panic attacks.
Certain medical conditions that produce symptoms similar to panic attacks
• Alcohol Withdrawal Syndrome
• Substance Withdrawal Syndrome
• Cardiac arrhythmias
• Hyperthyroidism
• Hypoglycemia
• Asthma
• Cushing’s Disease
The majority of patients have challenging life events before the first panic 
attack occurs. Low socio-economic level, delay in treatment, presence of additional 
diagnoses cause a negative course in panic disorder.
Comorbidity: Depression is seen with social phobia, specific phobia, traumatic 
stress disorder and alcoholism.
Treatment: Specific serotonin reuptake inhibitors should be the first choice 
in the treatment of panic disorder. If the patient does not respond to treatment, 
switching to other specific serotonin reuptake inhibitors is recommended. If there 
is no response to two specific serotonin reuptake inhibitors and there is severe 
tolerance, it is recommended to switch to SNRI. Alprazolan is also highly effective. 
Drug treatment should last at least a year. Behavioral-cognitive psychotherapy is 
an effective method in panic disorder. This method attempts to change the patient’s 
perception of physical symptoms. It will be useful to teach breathing exercises to 
the patient [15].
4.4 Agoraphobia
Agoraphobia, which is shortly defined as the fear of open space, is the fear of 
being deprived of help or being in places where it is difficult to escape.
Treatment: Combination of pharmacotherapy and psychotherapy (behavioral, 
cognitive, virtual therapies) is recommended in its treatment. Benzodiazepines, 
SSRIs, tricyclic and tetracyclicantidepressants are recommended as diocological [15].
4.5 Social phobia (social anxiety disorder)
It is a disorder characterized by blushing, sweating, and trembling of the hands 
when one believes that s/he is perceived negatively by others while sitting or talk-
ing in public. The individual is afraid of social or performance situations where 
embarrassment can occur and firmly believes that s/he will be subject to possible 
reproach by others [12]. The onset of the symptoms of this disorder often occurs in 
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late childhood or early adolescence and becomes chronic and sometimes continues 
throughout life. It is equally prevalent in males and females (Puri & Treasaden, 
2011). The disorder affects social or occupational functionality or causes significant 
distress.
Treatment: In its treatment, the combination of psychotherapy and pharmaco-
therapy has an advantage over the individual application of both treatments. The 
drug groups to be used in the treatment of social phobia similar to other anxiety 
disorders are SSRIs, benzodiazepines, venlafaxine and busprone. MAO inhibitors 
such as phenelzine and moclobemide have been shown to be successful in severe 
cases [15].
4.6 Specific phobia
It is an excessive, illogical and meaningless fear of a specific object (snake, dog, 
etc.) or a situation (injection, darkness, etc.). Exposure to phobic stimulus pro-
duces compelling panic symptoms, including palpitations, sweating, dizziness and 
difficulty in breathing. Phobias can begin at any age. People can be phobic towards 
almost any object or situation. Those that start in childhood often disappear 
without treatment. But those that start in adulthood or are persistent often require 
therapeutic support. The disorder is diagnosed more often in females than in males 
[16]. The specific classification of simple phobias is given in Table 1.
Treatment: It is not enough to use drugs alone in the treatment of specific 
phobias. Behavioral therapy, insight-oriented therapy, virtual therapy and pharma-
cotherapy are at the forefront in its treatment [17]. The main principle of treatment 
should be exposure to the feared situation. When the phobia is accompanied by 
panic attacks, beta-adrenergic receptor antagonists or benzodiazepines can be used. 
The combined use of pharmacotherapy and psychotherapy may also be effective.
4.7 Generalized anxiety disorder
It is an anxiety disorder characterized by being chronic and unrealistic, and 
extreme anxiety that must last at least 6 months. Symptoms can cause distress to 
the person in social, professional and other important areas. Individuals with this 
disorder are constantly worried. Restlessness, excessive excitement, fatigue, sleep 
disturbance and muscle tension are significant symptoms. Anxiety often results in 
difficulty in making self-decisions, and the person seeks constant approval from 
those around him. They always feel like they are going to get bad news. It usually 
starts in childhood and adolescence [2].
Comorbidity: It is seen with depression and other anxiety disorders.
Treatment: Cognitive-behavioral, supportive and insight oriented therapy and 
pharmacotherapy have a role in its treatment. The main drug groups used in the 
Clinical name Feared object or situation
Acrophobia Heights
Agoraphobia Open spaces
Claustrophobia Closed spaces
Hematophobia Blood
Zoophobia Animals
Table 1. 
Specific classification of simple phobias.
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treatment are benzodiazepines, SSRI, buspirone and venlafaxine. Benzodiazepines 
in treatment should be started with the lowest dose of the therapeutic range to be 
used and the dose should be increased in case of unresponsiveness [1].
4.8  Anxiety disorder associated with another medical condition and substance/
medication-induced anxiety
Symptoms associated with these disorders are evaluated directly as a physiologi-
cal consequence of another medical condition or directly due to substance intoxica-
tion or deprivation or exposure to the drug. Many medical conditions are related to 
the development of anxiety symptoms. Some of these include cardiac conditions 
such as myocardial infarction, congestive heart failure and mitral valve prolapse, 
endocrine conditions such as hypoglycemia, hypo/hyperthyroidism and pheochro-
mocytoma, respiratory conditions such as chronic obstructive pulmonary disease 
and hyperventilation, and complex partial seizures, neoplasms and encephalitis [12].
5. Treatment methods in anxiety disorders
5.1 Cognitive - behavioral therapy
It is a widely used, successful and easy method in the treatment of anxiety 
disorders. This short-term treatment method focuses on changing the patient’s 
thoughts and behaviors. This treatment includes emotional and behavioral changes 
to help the person to adapt to the environment perceived to be dangerous, as well as 
the initial definition and restructuring of cognitions related to anxiety in the form 
of unreal interpretation of danger [9, 18–20]. In their study, Andrews et al. (2005) 
also found that virtual reality practice therapy is effective in treating public speak-
ing anxiety [21].
5.1.1 Systematic desensitization
In systematic desensitization, the patient is gradually exposed to the effect of 
phobia stimuli in real or imaginary situations. The concept was first introduced 
by Joseph Wolpe in 1958 and is based on the principles of behavior conditioning. 
Emphasis is placed on mutual inhibition or mutual conditioning [22].
Mutual inhibition is defined as limiting anxiety before trying to reduce avoidance 
behaviors. The rationale behind this concept is that individuals cannot be excited 
and relaxed at the same time, as relaxation is the opposite of anxiety [23].
There are two important elements in systematic desensitization by mutual 
inhibition:
1. Practicing relaxation techniques
2. Gradual exposure to fear stimuli in a relaxed state.
The individual is taught the art of relaxation by using techniques that are more 
effective for him/her (e.g. progressive relaxation, mental imagination, tension and 
relaxation, meditation). After the individual learns relaxation techniques, exposure 
to phobic stimuli is initiated. The patient is asked to rank hierarchically the situa-
tions that cause phobic stimuli from the most disturbing to the least disturbing. In 
case of maximum relaxation, the patient may be asked to visualize the phobic stim-
ulus in his/her mind. First of all, the exposure focuses on the phobic stimulus that 
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causes the least fear or anxiety. In subsequent sessions, the individual is exposed 
to the effects of increasingly more fearful stimuli. Sessions can be conducted in 
imaginary, real-life situations (live), or sometimes a combination of both [1].
5.1.2 Flooding therapy
Flooding is the therapeutic process that involves the patient participating in 
real-life events or imaginary situations that s/he thinks to be extremely fearful for a 
long time. Relaxation training is not part of the technique. Such sessions should be 
given a long period because short periods can be ineffective and even harmful. The 
sessions are terminated when the patient reacts significantly less than s/he did at the 
beginning of the sessions [24].
5.1.3 Relaxation exercise
Relaxation exercise is a method that effectively reduces tension and 
anxiety. It can be used alone or in conjunction with other cognitive-behavioral 
techniques [25].
5.2 Family therapy
Families have difficulties in understanding the symptoms of their relatives with 
anxiety disorders and may find it hard to tolerate, and this situation can disrupt the 
healthy family structure. It is important to remind family members of their roles 
in therapy and to emphasize that support is important. Besides, it is necessary to 
inform them about anxiety disorder symptoms and treatments [1]. In another study 
conducted, it was concluded that treatments aimed at reducing symptoms only were 
insufficient in the treatment of anxiety disorders and that programs for improving 
interpersonal relationships, communication skills and anger management of the 
individual should be added [26].
5.3 Psychopharmacology
Anxiolytics: Benzodiazepines are used successfully in the treatment of common 
anxiety disorders. It can be prescribed when the patient is particularly anxious. 
Alprazolam, lorazepam and clonazepam are particularly effective in treating panic 
disorder. In Benzodiazepine treatment, there are physical addiction and tolerance 
risks that can lead to addiction. This is because deprivation symptoms can be 
life-threatening, so patients should be warned against sudden termination of drug 
intake, and drug termination should be done with treatment. Due to potential for 
addiction, benzodiazepines, SSRIs, serotonin, and norepinephrine reuptake inhibi-
tors (SNRs), and buspirone are the first-line therapy [27].
Buspirone, which as an anti-anxiety agent, is effective in approximately 60% 
to 80% of patients with a generalized anxiety disorder [3]. The only disadvantage 
of buspirone is the 10-14 day delay in relieving symptoms. However, the lack of 
physical addiction and tolerance disadvantage of buspirone makes it the drug of 
choice in the treatment of generalized anxiety disorders. The effects and side effects 
of anxiolytic agents are given in Table 2.
Antidepressants: Many antidepressants are as effective as anti-anxiety agents. 
Tricyclic, clomipramine and imipramine drugs are used successfully in patients 
with panic disorder. However, after the discovery of SSRIs, tricyclics are used less 
frequently because they tend to cause side effects when given in desired high doses 
to alleviate panic disorder symptoms [15].
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SSRIs are effective in treating panic disorders. Paroxetine, fluoxetine, and 
sertraline have been approved by the US Food and Drug Administration (FDA) for 
these purposes. The dosage of these drugs should be increased gradually, as patients 
with panic disorder are sensitive to overstimulation caused by SSRIs [1].
The use of anti-depressants in the treatment of generalized anxiety disorders is 
still under investigation. Some success has been reported with tricyclic, imipramine 
and SSRI drugs. The FDA has approved paroxetine, escitalopram, duloxetine and 
extended-release venlafaxine for the treatment of generalized anxiety disorders [28].
Beta blockers: Clonid and beta-blockers such as propranolol and atenolol are also 
used especially in maintenance treatment. These drugs are most effective in treating 
state anxiety [1].
Anxiolytic agents Effect Side effects
Benzodiazepines The GABA receptor increases the 
affinity of GABAA.
Sedation, dizziness, weakness, ataxia, 
decreased motor performance, 
addiction, withdrawal
SSRIs Inhibiting serotonin reuptake at the 
presynaptic nerve end, increasing 
serotonin synaptic concentration.
Nausea, diarrhea, headache, 
insomnia, sleepiness, sexual 
dysfunction
SNRIs Inhibition of neural serotonin and 
norepinephrine reuptake, mild 
reuptake of dopamine
Headache, dry mouth, nausea, 
drowsiness, insomnia, weakness, 
dizziness, constipation, diarrhea
Noradrenergic agents 
(propranolol, clonidine)
Propranolol: inhibits beta 
adrenergic receptor activity. 
Clonidine: stimulates alpha-
adrenergic receptors.
Propranolol: bradycardia, 
hypotension, weakness, fatigue, 
impotence, gastrointestinal disorder, 
bronchospasm
Barbiturates CNS depression also produces 
effects in the hepatic and 
cardiovascular systems.
Clonidine: dry mouth, sedation, 
fatigue, hypotension
Buspirone 5-HT1A receptor partial antagonist Drowsiness, agitation, confusion, 
ataxia, dizziness, bradycardia, 
hypotension, constipation
Table 2. 
Anxiolytic agents.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
11
Anxiety Disorders
DOI: http://dx.doi.org/10.5772/intechopen.93952
References
[1] Townsend, M.C., Psychiatric mental 
health nursing: Concepts of care in 
evidence-based practice. 2014: FA Davis.
[2] Combs, H. and J. Markman, Anxiety 
disorders in primary care. Medical 
Clinics, 2014. 98(5): p. 1007-1023.
[3] Sadock, B.J. and V.A. Sadock, 
Synopsis of psychiatry: Behavioral 
sciences/clinical psychiatry. Vol. 
10. 2007, Philadephia: Lippincott 
Williams&Wilkins.
[4] Black, D.W. and N.C. Andreasen, 
Introductory textbook of psychiatry. 
5 ed. 2011, Washington: American 
Psychiatric Publishing.
[5] Doğan, O., The epidemiology of 
anxiety disorders. Anatolian Journal of 
Psychiatry, 2012. 13: p. 158-164.
[6] Baxter, A., et al., Global prevalence 
of anxiety disorders: a systematic review 
and meta-regression. Psychological 
medicine, 2013. 43(5): p. 897.
[7] Erol, N., C. Kılıç, and M. Ulusoy, 
Türkiye Ruh Sağlığı Profili Araştırması, 
Ana Rapor. 1998, Ankara.T. C. Sağlık 
Bakanlığı.
[8] Özcan, M., F. Uğuz, and A.S. Çilli, 
Ayaktan psikiyatri hastalarında yaygın 
anksiyete bozukluğunun yaygınlığı ve 
ek tanılar. Türk Psikiyatri Dergisi, 2006. 
17(4): p. 276-285.
[9] Meier, S. and J. Deckert, Genetics of 
anxiety disorders. Current psychiatry 
reports, 2019. 21(3): p. 2-8.
[10] Sevinçok, L., Yaygın anksiyete 
bozukluğunun nörobiyolojisi. Klinik 
Psikiyatri, 2007. 10: p. 3-12.
[11] Köroğlu, E. and H. Türkçapar, 
Psikotrerapi Yöntemleri, Kuramlar ve 
Uygulama Yönergeleri. 2013, Ankara: 
HYB Basım Yayın.
[12] Association, A.P., Diagnostic and 
statistical manual of mental disorders 
(DSM-5®). 2013, Arlington: American 
Psychiatric Pub.
[13] Erermiş, S., et al., Ayrılma 
anksiyetesi bozukluğu olan okul öncesi 
yaş grubu çocukların annelerinin mizaç 
özellikleri. Türk psikiyatri Dergisi, 
2009. 20(1): p. 14-21.
[14] Schneier, F., et al., A randomized 
controlled pilot trial of vilazodone 
for adult separation anxiety disorder. 
Depression and Anxiety, 2017. 34(12): 
p. 1085-1095.
[15] Reinhold, J. and K. Rickels, 
Pharmacological treatment for 
generalized anxiety disorder in 
adults: an update. Expert opinion on 
pharmacotherapy, 2015. 16(11): p. 
1669-1681.
[16] Varcarolis, E. and M. Halter, 
Psychiatric Mental Health Nursing. 
2010, America: Tom Wilhelm.
[17] Işıklı, S., Z. Baran, and S. Aslan, 
Özgül fobilerde sanal gerçeklik 
teknolojisi uygulamaları ile tedaviye 
yardımcı araç geliştirme: Bir etkililik 
çalışması. Klinik Psikiyatri Dergisi, 
2019. 22(3): p. 316-328.
[18] Arch, J.J., et al., Longitudinal 
treatment mediation of traditional 
cognitive behavioral therapy and 
acceptance and commitment therapy for 
anxiety disorders. Behaviour Research 
and Therapy, 2012. 50(7): p. 469-478.
[19] Fıstıkcı, N., et al., Sosyal anksiyete 
bozukluğunda bilişsel davranışçı terapi: 
Güncel kavramlar. Psikiyatride Güncel 
Yaklaşımlar, 2015. 7(3): p. 229-243.
[20] Kaval, N.O. and S.T. Sütcü, Çocuk 
ve Ergenlerde Sosyal Anksiyete 
Bozukluğunun Tedavisinde Bilişsel-
Davranışçı Grup Terapisinin Etkililiği: 
Anxiety Disorders
12
Sistematik Bir Gözden Geçirme. 
Psikiyatride Güncel Yaklaşımlar, 2016. 
8(Ek 1): p. 3-22.
[21] Andrews, G., M. Davies, and 
N. Titov, Effectiveness randomized 
controlled trial of face to face versus 
Internet cognitive behaviour therapy 
for social phobia. Australian and New 
Zealand Journal of Psychiatry, 2011. 
45(4): p. 337-340.
[22] Obi, J. and A. Oguzie, Effects of 
systematic desensitization technique 
on generalized anxiety among 
adolescents in Enugu East Local 
Government. Enugu State, Nigeria. 
iJournals: International Journal of Social 
Relevance & Concern, 2019. 7(5): p. 1-9.
[23] Bulantika, S., M. Wibowo, and M. 
Jafar, Group Counseling with Systematic 
Desensitization Techniques and 
Thought-Stopping Techniques to Reduce 
Social Anxiety. Jurnal Bimbingan 
Konseling, 2018. 7(2): p. 106-112.
[24] Zbozinek, T. and M. Craske, The 
role of positive affect in enhancing 
extinction learning and exposure 
therapy for anxiety disorders. Journal 
of Experimental Psychopathology, 2017. 
8(1): p. 13-39.
[25] Zou, L., et al., Mindfulness-based 
Baduanjin exercise for depression and 
anxiety in people with physical or 
mental illnesses: a systematic review 
and meta-analysis. International journal 
of environmental research and public 
health, 2018. 15(2): p. 321.
[26] Şahin, N.H., A.D. Batıgün, and C. 
Uzun, Anksiyete bozukluğu: Kişilerarası 
tarz, kendilik algısı ve öfke açısından 
bir değerlendirme. Anadolu Psikiyatri 
Dergisi, 2011. 12(2): p. 107-113.
[27] Bandelow, B., et al., Efficacy of 
treatments for anxiety disorders: a 
meta-analysis. International clinical 
psychopharmacology, 2015. 30(4): 
p. 183-192.
[28] Cuijpers, P., et al., Adding 
psychotherapy to antidepressant 
medication in depression and anxiety 
disorders: a meta-analysis. World 
Psychiatry, 2014. 13(1): p. 56-67.
